170 related articles for article (PubMed ID: 16872642)
1. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains.
Kuhlmann CR; Lessmann V; Luhmann HJ
Neuropharmacology; 2006 Sep; 51(4):907-13. PubMed ID: 16872642
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro.
Kuhlmann CR; Gerigk M; Bender B; Closhen D; Lessmann V; Luhmann HJ
Life Sci; 2008 Jun; 82(25-26):1281-7. PubMed ID: 18534629
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption.
Kuhlmann CR; Tamaki R; Gamerdinger M; Lessmann V; Behl C; Kempski OS; Luhmann HJ
J Neurochem; 2007 Jul; 102(2):501-7. PubMed ID: 17419808
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide mediates cyclosporine-induced impairment of the blood-brain barrier in cocultures of mouse brain endothelial cells and rat astrocytes.
Dohgu S; Yamauchi A; Nakagawa S; Takata F; Kai M; Egawa T; Naito M; Tsuruo T; Sawada Y; Niwa M; Kataoka Y
Eur J Pharmacol; 2004 Nov; 505(1-3):51-9. PubMed ID: 15556136
[TBL] [Abstract][Full Text] [Related]
5. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
6. Adenosine induces dephosphorylation of myosin II regulatory light chain in cultured bovine corneal endothelial cells.
Srinivas SP; Satpathy M; Gallagher P; Larivière E; Van Driessche W
Exp Eye Res; 2004 Oct; 79(4):543-51. PubMed ID: 15381038
[TBL] [Abstract][Full Text] [Related]
7. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.
Kraus J; Ling AK; Hamm S; Voigt K; Oschmann P; Engelhardt B
Ann Neurol; 2004 Aug; 56(2):192-205. PubMed ID: 15293271
[TBL] [Abstract][Full Text] [Related]
8. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.
Wong D; Dorovini-Zis K; Vincent SR
Exp Neurol; 2004 Dec; 190(2):446-55. PubMed ID: 15530883
[TBL] [Abstract][Full Text] [Related]
9. Effects of pericytes and various cytokines on integrity of endothelial monolayer originated from blood-nerve barrier: an in vitro study.
Iwasaki T; Kanda T; Mizusawa H
J Med Dent Sci; 1999 Mar; 46(1):31-40. PubMed ID: 12160211
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
Aoki C; Nakano A; Tanaka S; Yanagi K; Ohta S; Jojima T; Kasai K; Takekawa H; Hirata K; Hattori Y
Int J Cardiol; 2012 Apr; 156(1):55-61. PubMed ID: 21093076
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues.
Fish RJ; Yang H; Viglino C; Schorer R; Dunoyer-Geindre S; Kruithof EK
Biochem J; 2007 Aug; 405(3):597-604. PubMed ID: 17472573
[TBL] [Abstract][Full Text] [Related]
12. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures.
John TA; Ibe BO; Raj JU
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):148-58. PubMed ID: 17892503
[TBL] [Abstract][Full Text] [Related]
13. Chlorpyrifos alters functional integrity and structure of an in vitro BBB model: co-cultures of bovine endothelial cells and neonatal rat astrocytes.
Parran DK; Magnin G; Li W; Jortner BS; Ehrich M
Neurotoxicology; 2005 Jan; 26(1):77-88. PubMed ID: 15527875
[TBL] [Abstract][Full Text] [Related]
14. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.
Santaguida S; Janigro D; Hossain M; Oby E; Rapp E; Cucullo L
Brain Res; 2006 Sep; 1109(1):1-13. PubMed ID: 16857178
[TBL] [Abstract][Full Text] [Related]
15. Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells.
Srinivas SP; Satpathy M; Guo Y; Anandan V
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4011-8. PubMed ID: 16936117
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S
Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234
[TBL] [Abstract][Full Text] [Related]
17. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
[TBL] [Abstract][Full Text] [Related]
18. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide.
Boveri M; Kinsner A; Berezowski V; Lenfant AM; Draing C; Cecchelli R; Dehouck MP; Hartung T; Prieto P; Bal-Price A
Neuroscience; 2006; 137(4):1193-209. PubMed ID: 16343789
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-induced perturbations in a cell culture model of the blood-brain barrier.
Hurst RD; Fritz IB
J Cell Physiol; 1996 Apr; 167(1):89-94. PubMed ID: 8698845
[TBL] [Abstract][Full Text] [Related]
20. MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion.
Kuhlmann CR; Zehendner CM; Gerigk M; Closhen D; Bender B; Friedl P; Luhmann HJ
Neurosci Lett; 2009 Jan; 449(3):168-72. PubMed ID: 18996441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
